drugset / Trial / NCT01253265
A Study in Rheumatoid Arthritis
RandomizedFactorialQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability of multiple doses of LY2439821 in Japanese patients with rheumatoid arthritis.
Timeline
- Start
- 2010-05
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ixekizumab | Monoclonal antibody | 30 mg | Subcutaneous |
| Subject | Ixekizumab | Monoclonal antibody | 80 mg | Subcutaneous |
| Subject | Ixekizumab | Monoclonal antibody | 120 mg | Subcutaneous |
| Subject | Ixekizumab | Monoclonal antibody | 180 mg | Subcutaneous |